CAP-100

· Catapult Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAP-100, covering 2025-07-17 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia [Phase 1]